Grannus Therapeutics Inc.

New Filing
CIK: 0001905806·Biotechnology·DELAWARE·Filed: Jan 21, 2022
Total Offering

$1,000,000

Amount Sold

$950,000

Investors

11

First Sale

Jan 12, 2022

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2020
Non-Accredited Investors
No

Related Persons

NameRole
John Foglesong
Related Person
Brian Blagg
Related Person
James Thompson
Related Person

Company

Grannus Therapeutics, Inc.

7210 N. PENNSYLVANIA STREET

INDIANAPOLIS, IN, 46240

3174146205

SEC Filing

0001905806-22-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Grannus Therapeutics Inc. Form D Filing — $1,000,000 | FilingFlow